169 related articles for article (PubMed ID: 37261285)
1. Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms.
Zhu PC; Shen J; Qian RY; Xu J; Liu C; Hu WM; Zhang Y; Lv LC
Front Pharmacol; 2023; 14():1165212. PubMed ID: 37261285
[No Abstract] [Full Text] [Related]
2. A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury.
Zheng Q; Zhu JZ; Bao XY; Zhu PC; Tong Q; Huang YY; Zhang QH; Zhang KJ; Zheng GQ; Wang Y
Front Physiol; 2018; 9():795. PubMed ID: 30018562
[TBL] [Abstract][Full Text] [Related]
3. Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms.
Zheng Q; Huang YY; Zhu PC; Tong Q; Bao XY; Zhang QH; Zheng GQ; Wang Y
Front Pharmacol; 2018; 9():729. PubMed ID: 30090062
[TBL] [Abstract][Full Text] [Related]
4. Ginkgolide B for Myocardial Ischemia/Reperfusion Injury: A Preclinical Systematic Review and Meta-Analysis.
Zhu PC; Tong Q; Zhuang Z; Wang ZH; Deng LH; Zheng GQ; Wang Y
Front Physiol; 2019; 10():1292. PubMed ID: 31681006
[TBL] [Abstract][Full Text] [Related]
5. Studies on the active constituents in radix salviae miltiorrhizae and their protective effects on cerebral ischemia reperfusion injury and its mechanism.
Li YH; Wang FY; Feng CQ; Yang XF
Pharmacogn Mag; 2015; 11(41):69-73. PubMed ID: 25709213
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibits ischemia-reperfusion-induced inflammation, ferroptosis and apoptosis through activation of the PI3K/Akt/mTOR pathway.
Zhang R; Liu Y; You J; Ge B
Hum Exp Toxicol; 2023; 42():9603271231180864. PubMed ID: 37314409
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
Li Q; Shen L; Wang Z; Jiang HP; Liu LX
Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
[TBL] [Abstract][Full Text] [Related]
8. Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms.
Huang YY; Wu JM; Su T; Zhang SY; Lin XJ
Front Pharmacol; 2018; 9():1083. PubMed ID: 30327600
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway.
Yuan X; Jing S; Wu L; Chen L; Fang J
Exp Ther Med; 2014 Sep; 8(3):973-977. PubMed ID: 25120632
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms.
Zheng Q; Bao XY; Zhu PC; Tong Q; Zheng GQ; Wang Y
Oxid Med Cell Longev; 2017; 2017():6313625. PubMed ID: 29430282
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA improves cardiac function via regulating miR-499-5p dependent angiogenesis in myocardial ischemic mice.
Wang X; Wu C
Microvasc Res; 2022 Sep; 143():104399. PubMed ID: 35697130
[TBL] [Abstract][Full Text] [Related]
12. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J
Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.
Tong Y; Xu W; Han H; Chen Y; Yang J; Qiao H; Hong D; Wu Y; Zhou C
Phytomedicine; 2011 Apr; 18(6):443-50. PubMed ID: 21146968
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA reduces pyroptosis in rats with coronary microembolization by inhibiting the TLR4/MyD88/NF-κB/NLRP3 pathway.
Li HL; Li T; Chen ZQ; Li L
Korean J Physiol Pharmacol; 2022 Sep; 26(5):335-345. PubMed ID: 36039734
[TBL] [Abstract][Full Text] [Related]
15. Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool.
Bao XY; Zheng Q; Tong Q; Zhu PC; Zhuang Z; Zheng GQ; Wang Y
Front Pharmacol; 2018; 9():1445. PubMed ID: 30618743
[No Abstract] [Full Text] [Related]
16. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
Ren ZH; Tong YH; Xu W; Ma J; Chen Y
Phytomedicine; 2010 Mar; 17(3-4):212-8. PubMed ID: 19800776
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
18. The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathway.
Zhai P; Chen Q; Wang X; Ouyang X; Yang M; Dong Y; Li J; Li Y; Luo S; Liu Y; Cheng X; Zhu R; Hu D
Chin Med; 2024 Feb; 19(1):34. PubMed ID: 38419127
[TBL] [Abstract][Full Text] [Related]
19. Janus kinase/signal transducer and activator of transcription inhibitors enhance the protective effect mediated by tanshinone IIA from hypoxic/ischemic injury in cardiac myocytes.
Zhang MQ; Tu JF; Chen H; Shen Y; Pang LX; Yang XH; Sun RH; Zheng YL
Mol Med Rep; 2015 Apr; 11(4):3115-21. PubMed ID: 25502794
[TBL] [Abstract][Full Text] [Related]
20. The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats.
Wei B; Li WW; Ji J; Hu QH; Ji H
Atherosclerosis; 2014 Aug; 235(2):318-27. PubMed ID: 24911635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
